Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.6500
+0.0219 (3.48%)
At close: Feb 5, 2026
Clearside Biomedical Market Cap
Clearside Biomedical has a market cap or net worth of $3.4 million as of February 6, 2026. Its market cap has decreased by -95.14% in one year.
Market Cap
3.40M
Enterprise Value
58.21M
Revenue
3.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.65
Market Cap Chart
Since June 2, 2016, Clearside Biomedical's market cap has decreased from 142.02M to 3.40M, a decrease of -97.60%. That is a compound annual growth rate of -31.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 3.29M | -10.90% |
| Dec 31, 2025 | 3.69M | -94.88% |
| Dec 31, 2024 | 72.05M | -1.32% |
| Dec 29, 2023 | 73.02M | 8.31% |
| Dec 30, 2022 | 67.41M | -58.91% |
| Dec 31, 2021 | 164.08M | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 2, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orgenesis | 5.90M |
| Bioxytran | 5.37M |
| Enzon Pharmaceuticals | 5.21M |
| AXIM Biotechnologies | 4.89M |
| Nymox Pharmaceutical | 4.59M |
| Mosaic ImmunoEngineering | 3.62M |
| Vaccinex | 3.24M |
| Burzynski Research Institute | 2.77M |